Akzo Nobel India Ltd
NSE: AKZOINDIA BSE: 500710
₹2950.90
(-1.65%)
Sat, 14 Feb 2026, 03:49 am
Market Cap136.63B
PE Ratio6.87
Dividend3.33
Process Industries
Industrial Specialties
24.5KAkzo Nobel India Analysis
dividend
- Dividends per share have increased over the past 10 years.
- Dividends paid are well covered by earnings (2.3x coverage).
- Akzo Nobel India's pays a higher dividend yield than the bottom 25% of dividend payers in India (0.76%).
- Dividends per share have been volatile in the past 10 years (annual drop of over 20%).
- Akzo Nobel India's dividend is below the markets top 25% of dividend payers in India (3.08%).
health
- Akzo Nobel India is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
- Akzo Nobel India is profitable, therefore cash runway is not a concern.
- Akzo Nobel India is profitable, therefore cash runway is not a concern.
- Debt is well covered by operating cash flow (1825.5%, greater than 20% of total debt).
- Debt is covered by short term assets, assets are 108.9x debt.
- Akzo Nobel India's cash and other short term assets cover its long term commitments.
- Akzo Nobel India earns more interest than it pays, coverage of interest payments is not a concern.
- Akzo Nobel India's level of debt (1.1%) compared to net worth is satisfactory (less than 40%).
- High level of physical assets or inventory.
management
- Rajiv's remuneration is lower than average for companies of similar size in India.
- The average tenure for the Akzo Nobel India board of directors is less than 3 years, this suggests a new board.
- The average tenure for the Akzo Nobel India management team is less than 2 years, this suggests a new team.
misc
- Akzo Nobel India is not covered by any analysts.
- Akzo Nobel India has significant price volatility in the past 3 months.
past
- Akzo Nobel India's 1-year earnings growth exceeds its 5-year average (21.1% vs 4.5%)
- Akzo Nobel India's year on year earnings growth rate has been positive over the past 5 years.
- Akzo Nobel India used its assets more efficiently than the IN Chemicals industry average last year based on Return on Assets.
- Akzo Nobel India has efficiently used shareholders’ funds last year (Return on Equity greater than 20%).
- Akzo Nobel India's earnings growth has exceeded the IN Chemicals industry average in the past year (21.1% vs 9.1%).
- Akzo Nobel India's use of capital deteriorated last year versus 3 years ago (Return on Capital Employed).
value
- AKZOINDIA matched the Chemicals industry (2.2%) over the past year.
- AKZOINDIA outperformed the Market in India which returned -14.5% over the past year.
- Akzo Nobel India's share price is above the future cash flow value, it's not available at a moderate discount (< 20%).
- Akzo Nobel India's share price is above the future cash flow value, it's not available at a substantial discount (< 40%).
- Akzo Nobel India is overvalued based on assets compared to the IN Chemicals industry average.
- Akzo Nobel India is overvalued based on earnings compared to the IN Chemicals industry average.
- Akzo Nobel India is overvalued based on earnings compared to the India market.
- NSEI:AKZOINDIA is flat (-0.3%) underperforming the Chemicals industry which returned 6.9% over the past month.
- NSEI:AKZOINDIA is flat (-0.3%) underperforming the market in India which returned 8% over the past month.
Open Your Free Demat Account Now!
Facebook
Twitter
Instagram
LinkedIn
Youtube
Calculators
Popular Calculators
Group Stocks
Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800